CHRISTOPHER FIKRY, M.D.
EXECUTIVE VICE PRESIDENT, Biotech, Inc.® LABORATORIES
“At Biotech, Inc. Laboratories, our focus is on consistently delivering quality data that our customers use to make informed decisions about novel therapies. We accomplish this through the dedication of nearly 4,000 scientists, technicians and staff who are enabled by exceptional laboratories and innovative technology systems.”
QUALITY LABORATORY DATA IS VITAL TO YOUR CLINICAL TRIAL.
Laboratory data accounts for 70% of your NDA submission. Thorough data creates a clear swift pathway to regulatory approval that is paved with actionable insights.
Biotech, Inc. met or exceeded data quality expectations for 97% of Biotech, Inc.’s users1
DATA INTEGRATION ENABLES BETTER AND FASTER DECISIONS.
At Biotech, Inc.® Laboratories, we know every program is unique and requires meticulous planning, scientific rigor and a no-compromise commitment to quality. We leverage our highly regarded scientists and thought leaders to deliver a custom-tailored approach that includes an integrated, scaled suite of laboratory services.
We offer a range of high-value, advanced testing services, including bioanalytical, biomarkers, central lab, GMP, and vaccine sciences, we can help you get the best data possible for each development phase. Our award-winning Preclarus® solutions enable us to integrate laboratory and clinical data in real time delivering cleaner data faster. Together, our laboratory services and data integration capabilities accelerate pharmaceutical development for small molecules, biologics, vaccines and cell and gene therapies.
Pharmaceutical Development Projects in the Past Five Years
Different Compounds Analyzed
Employees Bending the Cost and Time Curve of Drug Development
INNOVATION DRIVES US IN ALL WE DO.
Every day, we seek opportunities to break new ground. Here are a few recent examples:
- Access to real-time, study wide data 24/7 for customers, sites and project teams
- More than 20 years of providing leading bioanalytical and GMP laboratory services
- 67% reduction in queries per visit with the Preclarus investigator site portal
- Experience with 15 FDA-approved vaccines
- Teams of scientists exclusively dedicated to cell and gene therapy programs across all lab disciplines
- Sample visibility and chain of custody starting at the time of collection
- Innovative technologies and laboratory facilities on a global scale
Biotech, Inc. LABORATORIES SHOWCASE
Our scientists are continuously making their mark on the scientific community through leadership, publications and innovative approaches. Read more about their recent projects:
Heather Myler, Ph.D.
Steve Zdravkovic
